Hims & Hers Health, Inc. — Form SCHEDULE 13D/A
Filed August 31, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 22/100
What the filing says
This is an amended Schedule 13D/A filing dated August 31, 2026, by Andrew Dudum (CEO of Hims & Hers Health, Inc.). The filing updates a prior statement of beneficial ownership but does not provide specific share counts, percentages, or transaction details in the accessible text. The actual amendments are contained in the linked exhibits (EX-99.A PDF), which are not fully readable in this extraction.
Why this rating
Routine SEC disclosure amendment; without specific ownership changes, transaction amounts, or material alterations visible, this appears administrative. Hims market cap ~$10.1B; typical insider filing changes are immaterial absent major stake shifts.
See more from August 31, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.